What is Neurogene, Inc. Common Stock's Market Cap?

Neurogene, Inc. Common Stock's Market Cap is $775.1M, based on as-reported figures from SEC (XBRL) filings.

What is Neurogene, Inc. Common Stock's Enterprise Value?

Neurogene, Inc. Common Stock's Enterprise Value is $549.7M, based on as-reported figures from SEC (XBRL) filings.

What is Neurogene, Inc. Common Stock's EV / EBITDA?

Neurogene, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Neurogene, Inc. Common Stock's Revenue (TTM)?

Neurogene, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Neurogene, Inc. Common Stock's Net Income (TTM)?

Neurogene, Inc. Common Stock's Net Income (TTM) is -$111.1M, based on as-reported figures from SEC (XBRL) filings.

What is Neurogene, Inc. Common Stock's EBITDA?

Neurogene, Inc. Common Stock's EBITDA is -$118.1M, based on as-reported figures from SEC (XBRL) filings.

What is Neurogene, Inc. Common Stock's Diluted EPS (TTM)?

Neurogene, Inc. Common Stock's Diluted EPS (TTM) is -5.55, based on as-reported figures from SEC (XBRL) filings.

What is Neurogene, Inc. Common Stock's Net Debt?

Neurogene, Inc. Common Stock's Net Debt is -$225.4M, based on as-reported figures from SEC (XBRL) filings.

Neurogene, Inc. Common Stock (NGNE) Financial Statements

Neurogene, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG005Y0QF99

XNAS · usd

38.73▲ 0.60 (1.58%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close38.13

Day's Range36.68 – 38.75

52-Week Range15.93 – 43.66

Volume228.3K

Avg Volume200.0K

Share Statistics

Shares Outstanding

Employees131

ExchangeXNAS

Listed2023-12-19

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Neurogene, Inc. Common Stock (NGNE)

What is Neurogene, Inc. Common Stock's Market Cap?: Neurogene, Inc. Common Stock's Market Cap is $775.1M, based on as-reported figures from SEC (XBRL) filings.
What is Neurogene, Inc. Common Stock's Enterprise Value?: Neurogene, Inc. Common Stock's Enterprise Value is $549.7M, based on as-reported figures from SEC (XBRL) filings.
What is Neurogene, Inc. Common Stock's EV / EBITDA?: Neurogene, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Neurogene, Inc. Common Stock's Revenue (TTM)?: Neurogene, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Neurogene, Inc. Common Stock's Net Income (TTM)?: Neurogene, Inc. Common Stock's Net Income (TTM) is -$111.1M, based on as-reported figures from SEC (XBRL) filings.
What is Neurogene, Inc. Common Stock's EBITDA?: Neurogene, Inc. Common Stock's EBITDA is -$118.1M, based on as-reported figures from SEC (XBRL) filings.
What is Neurogene, Inc. Common Stock's Diluted EPS (TTM)?: Neurogene, Inc. Common Stock's Diluted EPS (TTM) is -5.55, based on as-reported figures from SEC (XBRL) filings.
What is Neurogene, Inc. Common Stock's Net Debt?: Neurogene, Inc. Common Stock's Net Debt is -$225.4M, based on as-reported figures from SEC (XBRL) filings.